Jordi Rimola
Overview
Explore the profile of Jordi Rimola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
5438
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saborido B, Darnell A, Forner A, Garcia-Criado A, Diaz A, Ayuso C, et al.
Eur Radiol
. 2025 Mar;
PMID: 40055232
Objective: In patients at risk of hepatocellular carcinoma (HCC), new focal liver lesions identified at ultrasound screening require further characterization by CT or MRI. If these techniques cannot conclusively characterize...
2.
Granel N, Iserte G, Bartres C, Llarch N, Pla A, Sapena V, et al.
BMC Gastroenterol
. 2025 Feb;
25(1):51.
PMID: 39901067
Background: The eradication of the Hepatitis C Virus (HCV) reduce the risk of liver cancer (LC), but lifestyle changes after cure may counterbalance its benefit. Our study investigates lifestyle changes...
3.
Matute-Gonzalez M, Darnell A, Comas-Cufi M, Pazo J, Soler A, Saborido B, et al.
Insights Imaging
. 2024 Nov;
15(1):280.
PMID: 39576290
Objective: To develop a domain-specific large language model (LLM) for LI-RADS v2018 categorization of hepatic observations based on free-text descriptions extracted from MRI reports. Material And Methods: This retrospective study...
4.
Rieder F, Baker M, Bruining D, Fidler J, Ehman E, Sheedy S, et al.
Radiology
. 2024 Oct;
313(1):e249020.
PMID: 39470432
No abstract available.
5.
Lu C, Rosentreter R, Parker C, Remillard J, Wilson S, Baker M, et al.
Lancet Gastroenterol Hepatol
. 2024 Oct;
9(12):1101-1110.
PMID: 39447590
Background: Diagnostic imaging using CT enterography, magnetic resonance enterography, and intestinal ultrasound are important tools in evaluating stricturing Crohn's disease. Definitions of strictures have been developed for CT enterography and...
6.
Mauro E, Sanduzzi-Zamparelli M, Jutras G, Garcia R, Soler Perromat A, Llarch N, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272917
Liver transplantation (LT) remains one of the most effective treatments for hepatocellular carcinoma (HCC) and significantly enhances patient survival. However, the application of LT for HCC faces challenges owing to...
7.
Reves J, Fernandez-Clotet A, Ordas I, Buisson A, Bazoge M, Hordonneau C, et al.
Clin Gastroenterol Hepatol
. 2024 Aug;
PMID: 39209193
Background & Aims: Transmural healing (TH) is emerging as a potential Crohn's disease (CD) treatment target. Early biological treatment seems to be associated with improved disease outcomes, but its impact...
8.
Rieder F, Ma C, Hanzel J, Fletcher J, Baker M, Wang Z, et al.
Radiology
. 2024 Aug;
312(2):e233038.
PMID: 39105638
Background Standardized methods to measure and describe Crohn disease strictures at CT enterography are needed to guide clinical decision making and for use in therapeutic studies. Purpose To assess the...
9.
Rieder F, Baker M, Bruining D, Fidler J, Ehman E, Sheedy S, et al.
Radiology
. 2024 Aug;
312(2):e233039.
PMID: 39105637
Background Clinical decision making and drug development for fibrostenosing Crohn disease is constrained by a lack of imaging definitions, scoring conventions, and validated end points. Purpose To assess the reliability...
10.
Bettenworth D, Baker M, Fletcher J, Jairath V, Lu C, Bemelman W, et al.
Nat Rev Gastroenterol Hepatol
. 2024 Jun;
21(8):572-584.
PMID: 38831007
Fibrostenosis of the small bowel is common in patients with Crohn's disease. No consensus recommendations on definition, diagnosis and management in clinical practice are currently available. In this Consensus Statement,...